pertuzumab,pembrolizumab,dostarlimab,talazoparib,durvalumab,trastuzumab,olaparib,paclitaxel,neratinib,cemiplimab,ganetespib,irinotecan,tucatinib
gsk,bms,amgen,astrazeneca,daiichi sankyo,merck,roche
['i-spy', 'lumina']
#asco22 #mlmasco - genius level iq is required to understand the i-spy trial design and its results presented at asco. need to look further too many subclassifications for luminal ebc
"What we cannot speak about we must pass over in silence" (L. Wittgenstein)